ASDS Survey: Consumers Rate Soft-tissue Treatments Tops; Choose Dermatologic Surgeons for Procedure
Tied for the highest overall satisfaction rating of 92 percent, soft-tissue fillers received the highest “extremely satisfied” rating (45 percent) from consumers.
Rolling Meadows, IL (PRWEB) July 26, 2013
Consumers are satisfied with soft-tissue filler treatments 92 percent of the time, a procedure they seek more often from dermatologic surgeons than other providers, according to survey data released by the American Society for Dermatologic Surgery.
The first-ever ASDS Consumer Survey on Cosmetic Dermatologic Procedures asked more than 6,300 consumers for their opinions on cosmetic treatments in general and ratings for 10 specific procedures – from ultrasound/light treatments and body sculpting to laser hair removal.
Although tied with the highest overall satisfaction rating of the 10 categories (92 percent – with wrinkle-relaxing injections), soft-tissue fillers received the highest “extremely satisfied” rating (45 percent) from consumers. Another 47 percent said they were “moderately satisfied.”
Soft-tissue fillers add volume to facial creases and folds that have lost fat and collagen through aging. Through a few tiny facial injections, skin is rejuvenated by reducing or eliminating wrinkles, raising scar depressions, enhancing lips and replacing soft-tissue volume loss.
Several types of fillers – each with its own specific purpose or purposes – are available, including Juvederm (Allergan), Radiesse (Merz), Restylane/Perlane (Medicis) and Sculptra (Dermik).
While survey respondents listed excess weight as their greatest cosmetic concern, more than half also are bothered by conditions treatable with soft-tissue fillers – mid-face folds and wrinkles, skin texture, sagging facial skin and lines and wrinkles around the eyes.
ASDS members performed more than 917,000 soft-tissue filler treatments in 2012, up 10.4 percent from the nearly 831,000 treatments performed in 2011, according to the 2012 ASDS Survey on Dermatologic Procedures.
“ASDS members have the training and expertise that makes them the obvious choice for patients to achieve the desired results with minimally invasive treatments,” said ASDS President Timothy C. Flynn, M.D. “ASDS members are the skin experts.”
More than half of survey respondents (53 percent) said they are considering soft-tissue fillers in the future. When asked why they have not yet had a treatment, respondents listed cost (78 percent), concerns over not getting the desired results (32 percent) and uncertainty about which practitioner to see (23 percent) as the most common reasons.
The 5 percent of survey respondents who had soft-tissue fillers indicated that dermatologists were their physician of choice and, of those, more than three out of five say their treatment was performed by a dermatologic surgeon.
“As consumers become more interested in cosmetic procedures such as soft-tissue fillers, they are increasingly turning to ASDS members,” Dr. Flynn said. “Advances in technology have made many of these procedures more affordable today than they have ever been.”
Consumers undergoing more than one cosmetic procedure rated soft-tissue fillers (21 percent) as the procedure that gave them the second best result, behind only wrinkle-relaxing injections (26 percent).
About the ASDS
The American Society for Dermatologic Surgery (ASDS) is the largest specialty organization exclusively representing dermatologic surgeons who have unique training and experience to treat the health, function and beauty of the skin. ASDS members are pioneers in the field. Many are involved in the clinical studies that bring popular treatments to revitalize skin and fill and diminish wrinkles to the forefront. Their work has helped create and enhance many of the devices that remove blemishes, hair and fat, and tighten skin. ASDS members also are experts in skin cancer prevention, detection and treatment. As the incidence of skin cancer rises, ASDS members are committed to taking steps to minimize the life-threatening effects of this disease. For more information, visit asds.net.
For the original version on PRWeb visit: http://www.prweb.com/releases/2013/7/prweb10964585.htm